These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26708526)

  • 1. Spectrum of phenotype and genotype of congenital isolated hypogonadotropic hypogonadism in Asian Indians.
    Nair S; Jadhav S; Lila A; Jagtap V; Bukan A; Pandit R; Ekbote A; Dharmalingam M; Kumar P; Kalra P; Gandhi P; Walia R; Sankhe S; Raghavan V; Shivane V; Menon P; Bandgar T; Shah N
    Clin Endocrinol (Oxf); 2016 Jul; 85(1):100-9. PubMed ID: 26708526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization.
    Quinton R; Duke VM; Robertson A; Kirk JM; Matfin G; de Zoysa PA; Azcona C; MacColl GS; Jacobs HS; Conway GS; Besser M; Stanhope RG; Bouloux PM
    Clin Endocrinol (Oxf); 2001 Aug; 55(2):163-74. PubMed ID: 11531922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
    Pitteloud N; Meysing A; Quinton R; Acierno JS; Dwyer AA; Plummer L; Fliers E; Boepple P; Hayes F; Seminara S; Hughes VA; Ma J; Bouloux P; Mohammadi M; Crowley WF
    Mol Cell Endocrinol; 2006 Jul; 254-255():60-9. PubMed ID: 16764984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics.
    Oliveira LM; Seminara SB; Beranova M; Hayes FJ; Valkenburgh SB; Schipani E; Costa EM; Latronico AC; Crowley WF; Vallejo M
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1532-8. PubMed ID: 11297579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Acierno JS; Meysing A; Eliseenkova AV; Ma J; Ibrahimi OA; Metzger DL; Hayes FJ; Dwyer AA; Hughes VA; Yialamas M; Hall JE; Grant E; Mohammadi M; Crowley WF
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6281-6. PubMed ID: 16606836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Zhang C; Pignatelli D; Li JD; Raivio T; Cole LW; Plummer L; Jacobson-Dickman EE; Mellon PL; Zhou QY; Crowley WF
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17447-52. PubMed ID: 17959774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic continuum between Waardenburg syndrome and idiopathic hypogonadotropic hypogonadism in humans with SOX10 variants.
    Rojas RA; Kutateladze AA; Plummer L; Stamou M; Keefe DL; Salnikov KB; Delaney A; Hall JE; Sadreyev R; Ji F; Fliers E; Gambosova K; Quinton R; Merino PM; Mericq V; Seminara SB; Crowley WF; Balasubramanian R
    Genet Med; 2021 Apr; 23(4):629-636. PubMed ID: 33442024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of intragenic deletions in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
    Pedersen-White JR; Chorich LP; Bick DP; Sherins RJ; Layman LC
    Mol Hum Reprod; 2008 Jun; 14(6):367-70. PubMed ID: 18463157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome.
    Quaynor SD; Kim HG; Cappello EM; Williams T; Chorich LP; Bick DP; Sherins RJ; Layman LC
    Fertil Steril; 2011 Dec; 96(6):1424-1430.e6. PubMed ID: 22035731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism.
    Beranova M; Oliveira LM; Bédécarrats GY; Schipani E; Vallejo M; Ammini AC; Quintos JB; Hall JE; Martin KA; Hayes FJ; Pitteloud N; Kaiser UB; Crowley WF; Seminara SB
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1580-8. PubMed ID: 11297587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Children with idiopathic hypogonadotropic hypogonadism: clinical data analysis and mutations analysis of KAL1 and FGFR1 gene].
    Qin M; Gong C; Qi Z; Wu D; Liu M; Gu Y; Cao B; Li W; Liang X
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):942-7. PubMed ID: 25619354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and molecular aspects of congenital isolated hypogonadotropic hypogonadism].
    Tusset C; Trarbach EB; Silveira LF; Beneduzzi D; Montenegro L; Latronico AC
    Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):501-11. PubMed ID: 22218430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
    Kim HG; Kurth I; Lan F; Meliciani I; Wenzel W; Eom SH; Kang GB; Rosenberger G; Tekin M; Ozata M; Bick DP; Sherins RJ; Walker SL; Shi Y; Gusella JF; Layman LC
    Am J Hum Genet; 2008 Oct; 83(4):511-9. PubMed ID: 18834967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
    Cole LW; Sidis Y; Zhang C; Quinton R; Plummer L; Pignatelli D; Hughes VA; Dwyer AA; Raivio T; Hayes FJ; Seminara SB; Huot C; Alos N; Speiser P; Takeshita A; Van Vliet G; Pearce S; Crowley WF; Zhou QY; Pitteloud N
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3551-9. PubMed ID: 18559922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications.
    Lewkowitz-Shpuntoff HM; Hughes VA; Plummer L; Au MG; Doty RL; Seminara SB; Chan YM; Pitteloud N; Crowley WF; Balasubramanian R
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E136-44. PubMed ID: 22072740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations.
    Laitinen EM; Tommiska J; Sane T; Vaaralahti K; Toppari J; Raivio T
    PLoS One; 2012; 7(6):e39450. PubMed ID: 22724017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and associated phenotypes of PLXNA1 variants in normosmic and anosmic idiopathic hypogonadotropic hypogonadism.
    Kotan LD; Isik E; Turan I; Mengen E; Akkus G; Tastan M; Gurbuz F; Yuksel B; Topaloglu AK
    Clin Genet; 2019 Feb; 95(2):320-324. PubMed ID: 30467832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular characterization of a large sample of patients with hypogonadotropic hypogonadism.
    Bhagavath B; Podolsky RH; Ozata M; Bolu E; Bick DP; Kulharya A; Sherins RJ; Layman LC
    Fertil Steril; 2006 Mar; 85(3):706-13. PubMed ID: 16500342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Quinton R; Pearce S; Raivio T; Acierno J; Dwyer A; Plummer L; Hughes V; Seminara S; Cheng YZ; Li WP; Maccoll G; Eliseenkova AV; Olsen SK; Ibrahimi OA; Hayes FJ; Boepple P; Hall JE; Bouloux P; Mohammadi M; Crowley W
    J Clin Invest; 2007 Feb; 117(2):457-63. PubMed ID: 17235395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetics of hypogonadotropic hypogonadism.
    Bhagavath B; Layman LC
    Semin Reprod Med; 2007 Jul; 25(4):272-86. PubMed ID: 17594608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.